0.5201
0.52 (-8.56%)
As of Jun 14, 2022
Nrx Pharmaceuticals, Inc. [NRXP]
Source:
Company Overview
NRx is a clinical-stage pharmaceutical company which develops, through its wholly-owned operating subsidiary, NeuroRx, Inc., novel therapeutics for the treatment of central nervous system disorders. Our strategy is to apply innovative science to known molecules in the pursuit of therapies for high unmet needs, including lethal conditions.
Country | United States |
Headquarters | wilmington, delaware |
Phone Number | 484-254-6134 |
Industry | finance |
CEO | Stephen H. Willard |
Website |